z-logo
Premium
Determination of corypalmine in mouse blood by UPLC–MS/MS and its application to a pharmacokinetic study
Author(s) -
Wu Haiya,
Yan Qizhi,
Fan Zhehua,
Huang Miaoling,
He Jiamin,
Ma Jianshe,
Wang Xianqin
Publication year - 2018
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.4255
Subject(s) - chemistry , chromatography , formic acid , selected reaction monitoring , pharmacokinetics , electrospray ionization , ammonium acetate , bioavailability , high performance liquid chromatography , tandem mass spectrometry , detection limit , mass spectrometry , oral administration , pharmacology , medicine
In this work, a selective and sensitive ultra‐performance liquid chromatography tandem mass spectrometry method was established and validated for determination of corypalmine in mouse blood after oral or intravenous administration. A UPLC BEH C 18 column was used to separate corypalmine and berberrubine (internal standard) at 40°C. The mobile phase was composed of acetonitrile and 10 mmol/L ammonium acetate (containing 0.1% formic acid) at a flow rate of 0.4 mL/min, and the total run time was 4.0 min. Electrospray ionization in positive ion mode was applied; target fragment ions m / z 342.2 → 178.0 for corypalmine and m / z 322.1 → 307.0 for berberrubine were identified with multiple reaction monitoring mode. The linear range was 1–1000 ng/mL ( r  > 0.995) and the lower limit of quantification for corypalmine in plasma was 1.0 ng/mL. The intra‐ and inter‐day precisions were both <14%. The range of accuracy in this method was 97.5–109.0%. Mean recovery was >69.6%, and the matrix effect was 96.8–107.6%. Based on its high sensitivity, specificity and reliability, this method was successfully applied to study the pharmacokinetic parameters of corypalmine in mouse by oral and intravenous administration, and finally, the bioavailability of corypalmine was identified at 4.6%.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here